Clinical Laboratory Evaluation of the Biodistribution of a Radiolabeled Antimicrobial Peptide for Precision Radiopharmaceutical-Guided Radionuclide Therapy in Severe Pneumonia Among Immunocompromised Patients with Cancer
{{output}}
Background: Pneumonia in immunocompromised patients with cancer is associated with high morbidity, diagnostic uncertainty, and poor short-term outcomes. Precision radiopharmaceutical approaches may improve lesion localization, bi... ...
